Evaluating the Abuse Potential of NEURONTIN® When Taken Orally in Healthy Non-drug Dependent Participants With Sedative Drug Abuse Experience
Clinical trial NCT04570436 · COMPLETED
Trial details
- NCT number
- NCT04570436
- Sponsor
- Viatris Specialty LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2022-11-10
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.